Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02985450
Recruitment Status : Recruiting
First Posted : December 7, 2016
Last Update Posted : April 17, 2019
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
GlaxoSmithKline
Information provided by (Responsible Party):
University of Calgary

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020